Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05638269

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Conditions: Essential Hypertension, Liver Cancer, Nasopharyngeal Cancer, Pancreatic Cancer, Lung Cancer, Chronic Kidney Diseases, Acute Coronary Syndrome, Epilepsy, Gastric Cancer, Primary Aldosteronism, Subclinical hypothyroïdism

Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: 1
Enrollment: 12000
Sponsor: Zhujiang Hospital

Location: China

Summary

The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to systematically characterize the gut microbiota of various critical chronic diseases, compare the similarities and differences of the microbiome signatures linked to different regions and diseases, and further investigate their impacts on microbiota-based diagnostic models.

Eligibility Criteria

Inclusion Criteria:aged 18-75 years;living in the province where the hospital is located in the last three years;with a medical diagnosis of one of the target diseases;willing to provide written informed consent.Exclusion Criteria:female in pregnancy or lactation(unless the subject is pregnant women);with medical diagnoses of other serious illnesses;with a history of bariatric surgery or intestinal resection, except for appendectomy;individual who was treated with drugs in the preceding 1 month, including antibiotics, metformin, statins, acid inhibitor, probiotics, and probiotics; individuals having consumed yogurt more than 3 times in the preceding 1 month; heavy drinkers who have consumed more than 4 taels of liquor or 1000ml of beer; frequent alcohol consumers who have drunk per week in the last month.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05638269). StuddyBuddy aggregates publicly available trial information.